Antonia-Gerasimina Vasilopoulou

Ms. Antonia-Gerasimina Vasilopoulou


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2025 in Cells
Verified
Journal Article
Open access
PDF file
AVAntonia-Gerasimina Vasilopoulou
Antonia-Gerasimina Vasilopoulou
EKEleni Kalafati
Eleni Kalafati
EKATI DRAKOPOULOUEKATI DRAKOPOULOU
EKATI DRAKOPOULOU
NANicholas P. Anagnou
Nicholas P. Anagnou
Over recent years, epitranscriptomic research has provided a new layer of gene regulation during hematopoietic development and aberrant hematopoiesis. Among the 170 identified RNA chemical marks, N6-methyladenosine (m6A) is the most abundant in eukaryotic cells and plays a critical role in various biological processes. This dynamic modification is regulated by a series of methyltransferases, demethylases, and m6A binding proteins, known as writers, erasers, and readers, respectively. Emerging evidence suggests that m6A modification and its regulators are involved in every aspect of normal hematopoietic development, from the emergence of hematopoietic stem cells to the generation of mature blood cells. Also, it has been established that abnormal expression of m6A regulators is implicated in the initiation of blood diseases. In this review, we summarize the latest findings regarding the role of m6A in erythropoiesis and highlight its implications in the pathophysiology of hemoglobin disorders.